ALLMedicine™ Apraxia Center

Apr 9th, 2021 - We characterize the clinical and molecular phenotypes of six unrelated individuals with intellectual disability and autism spectrum disorder who carry heterozygous missense variants of the PRKAR1B gene, which encodes the R1β subunit of the cyclic ...

Apr 8th, 2021 - Background The Rapid Syllable Transition (ReST) treatment is an effective intervention designed to address the planning and programming disorder found in childhood apraxia of speech. To date, no study has considered its use with children who speak...

Apr 7th, 2021 - Apraxia of speech is a motor disorder characterized by the impaired ability to coordinate the sequential articulatory movements necessary to produce speech. The critical cortical area(s) involved in speech apraxia remain controversial because many...

Apr 7th, 2021 - Purpose Variability has been interpreted in differing ways according to context (e.g., development, speech impairment, and learning). A challenge arises when interpreting variability in the context of learning for children with speech impairment c...

Apr 2nd, 2021 - Backround Orofacial dysfunctions (OFD; orofacial myofunctional disorders) in children and childhood apraxia of speech (CAS) often cause severe problems in articulation, chewing, swallowing and oral posture. Pathognomonic symptoms could yet not be ...

Apr 9th, 2021 - We characterize the clinical and molecular phenotypes of six unrelated individuals with intellectual disability and autism spectrum disorder who carry heterozygous missense variants of the PRKAR1B gene, which encodes the R1β subunit of the cyclic ...

Apr 8th, 2021 - Background The Rapid Syllable Transition (ReST) treatment is an effective intervention designed to address the planning and programming disorder found in childhood apraxia of speech. To date, no study has considered its use with children who speak...

Apr 7th, 2021 - Apraxia of speech is a motor disorder characterized by the impaired ability to coordinate the sequential articulatory movements necessary to produce speech. The critical cortical area(s) involved in speech apraxia remain controversial because many...

Apr 7th, 2021 - Purpose Variability has been interpreted in differing ways according to context (e.g., development, speech impairment, and learning). A challenge arises when interpreting variability in the context of learning for children with speech impairment c...

Apr 2nd, 2021 - Backround Orofacial dysfunctions (OFD; orofacial myofunctional disorders) in children and childhood apraxia of speech (CAS) often cause severe problems in articulation, chewing, swallowing and oral posture. Pathognomonic symptoms could yet not be ...

Apr 25th, 2017 - Robert Chen, MBBChir MIAMI—Botulinum toxin may be a clinically useful treatment for motor and nonmotor manifestations of Parkinson’s disease and parkinsonism, according to an overview presented at the First Pan American Parkinson’s Disease and Mov.

Oct 26th, 2015 - Case Diagnosis This patient has oculomotor apraxia (OMA). In spasmus nutans, the head movement is a vertical nodding, and a fine asymmetric nystagmus is usually present. This patient does not have ptosis or eyelid movements that are consistent wit...

Oct 26th, 2015 - Discussion OMA, also known as infantile-onset saccade initiation delay, is characterized by an inability to initiate volitional horizontal eye movements.[1,2] American ophthalmologist David Cogan first described the condition in 1952 when he publi...

Jul 28th, 2005 - Action Points Be aware that patients with right hemispheric strokes are more likely to present with cognitive deficits or apraxia than with aphasia or paresis. In patients at risk for ischemic or hemorrhagic strokes consider the possibility of rig...